Immune Checkpoint Inhibitors in Esophageal Cancers: Are We Finally Finding the Right Path in the Mist?

Esophageal cancer remains a challenging disease due to limited treatment options and poor prognosis. In recent years, immune checkpoint inhibitors (ICI) have been proven to be safe and effective in the treatment of highly lethal malignancies, such as non-small cell lung cancer and melanoma. Recent c...

Descripción completa

Detalles Bibliográficos
Autores principales: Vivaldi, Caterina, Catanese, Silvia, Massa, Valentina, Pecora, Irene, Salani, Francesca, Santi, Stefano, Lencioni, Monica, Vasile, Enrico, Falcone, Alfredo, Fornaro, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084692/
https://www.ncbi.nlm.nih.gov/pubmed/32121290
http://dx.doi.org/10.3390/ijms21051658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7084692/
https://www.ncbi.nlm.nih.gov/pubmed/32121290
http://dx.doi.org/10.3390/ijms21051658

Ejemplares similares